scispace - formally typeset
A

Austin J. Yang

Researcher at University of Maryland, Baltimore

Publications -  54
Citations -  5894

Austin J. Yang is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Proteomics & Neurodegeneration. The author has an hindex of 28, co-authored 53 publications receiving 5470 citations. Previous affiliations of Austin J. Yang include New York University & University of Maryland Marlene and Stewart Greenebaum Cancer Center.

Papers
More filters
Journal ArticleDOI

A specific amyloid-|[beta]| protein assembly in the brain impairs memory

TL;DR: It is found that memory deficits in middle-aged Tg2576 mice are caused by the extracellular accumulation of a 56-kDa soluble amyloid-β assembly, which is proposed to be Aβ*56 (Aβ star 56), which may contribute to cognitive deficits associated with Alzheimer's disease.
Journal ArticleDOI

Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis.

TL;DR: The results suggest that the loss of lysosomal membrane impermeability may be an early event in Aβ pathogenesis, and provide an explanation for the miscompartmentalization of extracellular and cytoplasmic components observed in Alzheimer's disease (AD).
Journal ArticleDOI

Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation

TL;DR: It was found that soluble PHF-Tau is ubiquitinated at its microtubule-binding domain at residues Lys-254, Lys-311, and Lys-353, suggesting that ubiquitination of PHF -Tau may be an earlier pathological event than previously thought and that Ubiquitination could play a regulatory role in modulating the integrity of microtubules during the course of AD.
Journal ArticleDOI

Complement component C1q modulates the phagocytosis of Abeta by microglia.

TL;DR: Mechanisms which interfere with the binding of C1q to Abeta may be of therapeutic value both through inhibition of the inflammatory events resulting from complement activation and via altered access of Abeta sites necessary for ingestion by microglia.